BR112018068686A2 - formulação de compósito de cápsula dura, formulação de compósito de dose fixa e método de preparação da formulação de compósito de cápsula dura - Google Patents
formulação de compósito de cápsula dura, formulação de compósito de dose fixa e método de preparação da formulação de compósito de cápsula duraInfo
- Publication number
- BR112018068686A2 BR112018068686A2 BR112018068686A BR112018068686A BR112018068686A2 BR 112018068686 A2 BR112018068686 A2 BR 112018068686A2 BR 112018068686 A BR112018068686 A BR 112018068686A BR 112018068686 A BR112018068686 A BR 112018068686A BR 112018068686 A2 BR112018068686 A2 BR 112018068686A2
- Authority
- BR
- Brazil
- Prior art keywords
- composite formulation
- hard capsule
- dutasteride
- preparing
- tamsulosin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160031468 | 2016-03-16 | ||
| PCT/KR2017/002862 WO2017160106A2 (ko) | 2016-03-16 | 2017-03-16 | 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018068686A2 true BR112018068686A2 (pt) | 2019-01-15 |
Family
ID=59850978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018068686A BR112018068686A2 (pt) | 2016-03-16 | 2017-03-16 | formulação de compósito de cápsula dura, formulação de compósito de dose fixa e método de preparação da formulação de compósito de cápsula dura |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR101968754B1 (ru) |
| CN (1) | CN109152743B (ru) |
| AU (1) | AU2017233134A1 (ru) |
| BR (1) | BR112018068686A2 (ru) |
| EA (1) | EA201891843A1 (ru) |
| MX (1) | MX2018011208A (ru) |
| PH (1) | PH12018501985A1 (ru) |
| WO (1) | WO2017160106A2 (ru) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW369521B (en) | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| UA80393C2 (ru) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице |
| ES2287613T3 (es) * | 2004-07-14 | 2007-12-16 | Siegfried Generics International Ag | Granulado para la liberacion controlada de tamsulosina, que contiene alginato. |
| WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
| CN102247379A (zh) * | 2011-01-12 | 2011-11-23 | 北京润德康医药技术有限公司 | 一种复方制剂及其制备方法 |
| CN102145007B (zh) * | 2011-03-03 | 2013-03-20 | 王致中 | 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法 |
| WO2014002015A1 (en) * | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
| EP2976068B1 (en) * | 2013-03-19 | 2018-05-30 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
| CN105073100A (zh) * | 2013-06-21 | 2015-11-18 | 沃克哈特有限公司 | 坦索罗辛或其盐的药物组合物 |
| EP2949319A1 (en) * | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
| KR101590072B1 (ko) * | 2014-12-23 | 2016-01-29 | 한미약품 주식회사 | 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물 |
-
2017
- 2017-03-16 BR BR112018068686A patent/BR112018068686A2/pt not_active Application Discontinuation
- 2017-03-16 AU AU2017233134A patent/AU2017233134A1/en not_active Abandoned
- 2017-03-16 KR KR1020170033369A patent/KR101968754B1/ko active IP Right Grant
- 2017-03-16 CN CN201780029107.0A patent/CN109152743B/zh active Active
- 2017-03-16 WO PCT/KR2017/002862 patent/WO2017160106A2/ko active Application Filing
- 2017-03-16 EA EA201891843A patent/EA201891843A1/ru unknown
- 2017-03-16 MX MX2018011208A patent/MX2018011208A/es unknown
-
2018
- 2018-09-14 PH PH12018501985A patent/PH12018501985A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017160106A2 (ko) | 2017-09-21 |
| MX2018011208A (es) | 2019-05-30 |
| CN109152743B (zh) | 2022-01-07 |
| AU2017233134A1 (en) | 2018-10-04 |
| PH12018501985A1 (en) | 2019-07-08 |
| EA201891843A1 (ru) | 2019-04-30 |
| KR20170107933A (ko) | 2017-09-26 |
| KR101968754B1 (ko) | 2019-04-12 |
| CN109152743A (zh) | 2019-01-04 |
| WO2017160106A3 (ko) | 2018-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
| BR112018077021A2 (pt) | terapias de combinação | |
| CO2019008487A2 (es) | Compuesto de quinazolina | |
| BR112017006957A2 (pt) | formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína | |
| BR112017010551A2 (pt) | composto, métodos para ativação de guanilato ciclase solúvel, para tratamento de uma ou mais condições selecionadas a partir de uma doença em um paciente e para tratamento de uma doença ou condição, composição farmacêutica, uso de um composto, e, medicamento. | |
| BR112014004967A2 (pt) | pré-concentrado lipídico de liberação sustentada e composição farmacêutica | |
| BR112016007946A2 (pt) | combinação farmacêutica, usos da mesma, de plinabulina e de composição, kits ou mistura e método para tratar e/ou prevenir câncer | |
| BR112017014740A2 (pt) | composto espiro tricíclico | |
| CL2019001447A1 (es) | Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos. | |
| BR112016004358A8 (pt) | combinação farmacêutica de um inibidor de alk e um inibidor de cdk para tratamento de doenças proliferativas de célula, composição farmacêutica, seus usos, e kit | |
| PE20130045A1 (es) | FORMULACIONES INTRAVENOSAS DE COENZIMA Q10 (CoQ10) Y METODOS DE USO DE LAS MISMAS | |
| BR112015023481A2 (pt) | composição de lipossoma de liberação controlada de fármaco | |
| BR112015022650A2 (pt) | inibidores de cinase induzível por sal macrocíclico | |
| AR100519A1 (es) | Envase tipo cápsula de gelatina blanda y su método de fabricación | |
| BR112013017302A2 (pt) | formulações de imunossupressor | |
| BR112015022385A2 (pt) | droga para uma doença respiratória | |
| BR112016017897A8 (pt) | uso de composto de carboxamida heterocíclica de diamino no tratamento de câncer relacionado ao axl, composição farmacêutica e combinação | |
| BR112015032728A2 (pt) | formulação compósita em cápsula farmacêutica compreendendo tadalafil e tansulosina | |
| WO2016100949A3 (en) | Method and compositions for dissolving or solubilizing therapeutic agents | |
| WO2016130800A3 (en) | Pharmaceutical compositions comprising perillyl alcohol derivatives | |
| BR112019024744A2 (pt) | Partícula e composição farmacêutica compreendendo um composto de camptotecina insolúvel com estrutura núcleo-casca dupla e método para produção da mesma | |
| Vermelho et al. | Leishmaniasis: possible new strategies for treatment | |
| BR112018009413A2 (pt) | formulação oral sólida e método para preparar a formulação oral sólida | |
| BR112018068000A2 (pt) | composições de nanolipossomas de geração de docetaxel direcionados ao receptor a2 de efrina (epha2) | |
| BR112018068686A2 (pt) | formulação de compósito de cápsula dura, formulação de compósito de dose fixa e método de preparação da formulação de compósito de cápsula dura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |